These immunomodulatory properties may enhance the effectiveness of conventional biologic therapies and could potentially support disease control in early PsA, although this possibility still requires confirmation in dedicated clinical studies, a phase in which immune dysregulation is still evolving
Mary Internal Medicine | The Remedy Room At The Remedy Room, every treatment is guided by medical expertise you can trust
Rajamand Ekberg N, Bodholdt U, Catarig AM, Catrina SB, Grau K, Holmberg CN, et al
10.1007/s12265-022-10303-3 94 LiuM.LiY
Ive never felt rushed during a consultation, even after all these years
Semaglutide was originally developed for type 2 diabetes management, so it is often an excellent choice for patients managing both diabetes and excess weight